Advertisement

Advertisement

TSE:LSL Stock Latest News

LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

Company AnnouncementsLSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

LSL Pharma Grants 960,000 Stock Options to Directors, Executives and Staff

PremiumCompany Announcements

LSL Pharma Grants 960,000 Stock Options to Directors, Executives and Staff

2M ago

LSL Pharma Wins FDA Nod for Ophthalmic Ointment Manufacturing, Unlocking U.S. Market Access

PremiumCompany Announcements

LSL Pharma Wins FDA Nod for Ophthalmic Ointment Manufacturing, Unlocking U.S. Market Access

3M ago

LSL Pharma Closes Juno OTC Acquisition and Completes $12 Million Financing Package

PremiumCompany Announcements

LSL Pharma Closes Juno OTC Acquisition and Completes $12 Million Financing Package

4M ago

LSL Pharma Raises $10 Million and Moves to Acquire Juno OTC

PremiumCompany Announcements

LSL Pharma Raises $10 Million and Moves to Acquire Juno OTC

4M ago

LSL Pharma Group Acquires Juno OTC Inc. and Secures $11M Fundraising

PremiumCompany AnnouncementsLSL Pharma Group Acquires Juno OTC Inc. and Secures $11M Fundraising

4M ago

LSL Pharma Group Achieves Record Q3 Revenues and Expands Operations

Company Announcements

LSL Pharma Group Achieves Record Q3 Revenues and Expands Operations

5M ago

LSL Pharma Group Expands Production Capacity with Du-Var Acquisition

Company Announcements

LSL Pharma Group Expands Production Capacity with Du-Var Acquisition

5M ago

LSL Pharma Gains Health Canada Approval for New Ophthalmic Solutions

PremiumCompany Announcements

LSL Pharma Gains Health Canada Approval for New Ophthalmic Solutions

6M ago

LSL Pharma Group Strengthens Board with New Appointments

PremiumCompany Announcements

LSL Pharma Group Strengthens Board with New Appointments

6M ago

LSL Pharma Group Secures $2.275M to Boost Growth and Expansion

PremiumCompany Announcements

LSL Pharma Group Secures $2.275M to Boost Growth and Expansion

7M ago

LSL Pharma Group Achieves Record Revenues and Expands Eye-Care Portfolio

PremiumCompany Announcements

LSL Pharma Group Achieves Record Revenues and Expands Eye-Care Portfolio

8M ago

LSL Pharma Group Completes Early Redemption of Debentures

PremiumCompany AnnouncementsLSL Pharma Group Completes Early Redemption of Debentures

8M ago

LSL Pharma Group to Acquire Quebec-Based Competitor, Boosting Revenue and Capacity

Company Announcements

LSL Pharma Group to Acquire Quebec-Based Competitor, Boosting Revenue and Capacity

9M ago

LSL Pharma Group Announces Early Redemption of Convertible Debentures

Company Announcements

LSL Pharma Group Announces Early Redemption of Convertible Debentures

10M ago

LSL Pharma Group Announces Key Decisions from Annual Shareholder Meeting

PremiumCompany Announcements

LSL Pharma Group Announces Key Decisions from Annual Shareholder Meeting

10M ago

LSL Pharma Group Secures $17.5 Million in New Financing

PremiumCompany Announcements

LSL Pharma Group Secures $17.5 Million in New Financing

10M ago

LSL Pharma Group Achieves Record Q1 Revenues and Expands Eye-Care Portfolio

PremiumCompany Announcements

LSL Pharma Group Achieves Record Q1 Revenues and Expands Eye-Care Portfolio

11M ago

LSL Pharma Group Achieves Record Revenues in Q1 2025 Amid Strategic Expansions

PremiumCompany Announcements

LSL Pharma Group Achieves Record Revenues in Q1 2025 Amid Strategic Expansions

11M ago

LSL Pharma Group Reports Strong Financial Turnaround in FY-24

PremiumCompany AnnouncementsLSL Pharma Group Reports Strong Financial Turnaround in FY-24

12M ago

LSL Pharma Group to Participate in 2025 Healthcare Investor Conference

Company Announcements

LSL Pharma Group to Participate in 2025 Healthcare Investor Conference

12M ago

LSL Pharma Group Announces Interest Payment and Rate Reduction Post-Acquisition

Company Announcements

LSL Pharma Group Announces Interest Payment and Rate Reduction Post-Acquisition

12M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >